Mycophenolate mofetil and Viral sepsis - a phase IV clinical study of FDA data
Summary:
Viral sepsis is reported as a side effect among people who take Mycophenolate mofetil (mycophenolate mofetil), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Tacrolimus, and have Microscopic polyangiitis.
The phase IV clinical study analyzes which people have Viral sepsis when taking Mycophenolate mofetil. It is created by eHealthMe based on reports of 93,176 people who have side effects when taking Mycophenolate mofetil from the FDA, and is updated regularly.
What is Mycophenolate mofetil?
Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,461 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.
What is Viral sepsis?
Viral sepsis is found to be associated with 22 drugs and 83 conditions by eHealthMe. Check the latest studies of Viral sepsis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
93,176 people reported to have side effects when taking Mycophenolate mofetil.
Among them, 15 people (0.02%) have Viral sepsis.

Among these 15 people:
How long have people been on Mycophenolate mofetil when they have Viral sepsis? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Viral sepsis when taking Mycophenolate mofetil? *
- female: 7.69 %
- male: 92.31 %
What is the age of people who have Viral sepsis when taking Mycophenolate mofetil? *
- 0-1: 0.0 %
- 2-9: 15.38 %
- 10-19: 7.69 %
- 20-29: 15.38 %
- 30-39: 7.69 %
- 40-49: 0.0 %
- 50-59: 7.69 %
- 60+: 46.15 %
What are other drugs people take besides Mycophenolate mofetil? *
- Tacrolimus: 3 people, 20.00%
- Methylprednisolone: 2 people, 13.33%
- Methotrexate: 2 people, 13.33%
- Cyclosporine: 2 people, 13.33%
- Busulfan: 2 people, 13.33%
- Zantac: 1 person, 6.67%
- Sirolimus: 1 person, 6.67%
- Rocephin: 1 person, 6.67%
- Protopic: 1 person, 6.67%
- Prednisolone: 1 person, 6.67%
What are other side effects people have besides Viral sepsis? *
- Hepatic Failure (liver failure): 6 people, 40.00%
- Human Herpesvirus 6 Infection: 5 people, 33.33%
- Bleeding Disorders: 4 people, 26.67%
- Fever: 4 people, 26.67%
- C-Reactive Protein Increased: 4 people, 26.67%
- Oropharyngeal Pain: 4 people, 26.67%
- Blood Creatinine Increased: 4 people, 26.67%
- Hepatitis Viral: 3 people, 20.00%
- Adenoviral Hepatitis (viral hepatitis): 3 people, 20.00%
- Rebound Effect (take-back effect): 3 people, 20.00%
What are the existing conditions these people have? *
- Microscopic Polyangiitis (inflammation involving multiple blood or lymph small-vessel): 4 people, 26.67%
- Immunodeficiency Disorders: 2 people, 13.33%
- Bone Marrow Conditioning Regimen: 2 people, 13.33%
- Transplant Rejection (a transplant material is not worked): 1 person, 6.67%
- Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 1 person, 6.67%
- Infection In An Immunocompromised Host: 1 person, 6.67%
- Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 1 person, 6.67%
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 6.67%
- Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Mycophenolate mofetil and have Viral sepsis?
- Check whether Viral sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Mycophenolate mofetil:
- Mycophenolate mofetil (93,461 reports)
Viral sepsis treatments and more:
- Viral sepsis (140 reports)
How severe was Viral sepsis and when was it recovered:
Expand to all the drugs that have ingredients of mycophenolate mofetil:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mycophenolate mofetil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Viral sepsis:
- Viral sepsis (22 drugs)
Browse all the conditions that are associated with Viral sepsis:
- Viral sepsis (83 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Anxiety Aggravated in Advair Diskus 100/50, how severe and when it was recovered? - 5 seconds ago
- Drug interactions of Aldactone and Erbitux - 6 seconds ago
- Could Seroquel Xr cause Mania? - 8 seconds ago
- Swelling Face and drugs of ingredients of fluticasone propionate; salmeterol xinafoate - 9 seconds ago
- Fluoxetine Hydrochloride vs. Fetzima, side effect and effectiveness comparison - 9 seconds ago
- Repaglinide and Thoughts - Cloudy for Men aged 60+ - 10 seconds ago
- Repaglinide and Thinking - Unclear for Men aged 60+ - 11 seconds ago
- Repaglinide and Disorientation for Men aged 60+ - 11 seconds ago
- Repaglinide and Confusion for Men aged 60+ - 11 seconds ago
- Hydrochlorothiazide and Dehydration for Women aged 40-49 - 13 seconds ago